A practical reference on GLP-1: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Reported molecular weight is approximately 4113.6 daltons for the free base, and the peptide is supplied as a lyophilized powder or in buffered liquid form depending on the intended use. It is freely soluble in water when formulated with appropriate excipients, though the unconjugated peptide shows limited stability at neutral pH over long periods. Analytical characterization typically relies on reversed-phase high-performance liquid chromatography and mass spectrometry. Purity specifications for research-grade material commonly exceed ninety-five percent by area. Isotopic and impurity profiles differ between suppliers.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.
| Property | Value | Notes |
|---|---|---|
| Molecular formula (free base) | C187H291N45O59 | Approximate; salt and hydrate forms differ |
| Molecular weight | ~4113.6 Da | Varies with counterion and hydration |
| Appearance | White to off-white powder | Lyophilized research material |
| Solubility class | Freely soluble in water | As formulated; native peptide less stable near neutral pH |
| Typical storage | 2 to 8 degrees Celsius | Protect from light; avoid repeated freeze-thaw |
The company that developed the compound filed it as a long-acting analogue, and it gained first approval in 2017 for type 2 diabetes. Later authorisations from several regulators extended the indication to chronic weight management, and the World Health Organization added the glucagon-like peptide-1 receptor agonist drug class to its model list of essential medicines in 2023. Production uses solid-phase peptide synthesis followed by side-chain conjugation and chromatographic purification. Supply constraints and cost differences across regions are well documented. Literature on long-term outcomes continues to grow, with many trials reporting surrogate endpoints rather than hard clinical endpoints.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.
Receptor activation raises intracellular cyclic AMP through Gs coupling, which promotes glucose-dependent insulin release and suppresses glucagon secretion when blood glucose is elevated. Effects outside the pancreas include slower gastric emptying and altered appetite signalling in the hypothalamus and hindbrain. The relative contribution of each tissue to overall metabolic outcomes remains an area of active investigation. Central mechanisms in particular are inferred mainly from animal models and indirect human measures rather than direct observation.
== Hematopoietic == Acute biphenotypic leukemia Acute eosinophilic leukemia Acute lymphoblastic leukemia Acute myeloid leukemia Acute myeloid dendritic cell leukemia AIDS-related lymphoma Anaplastic large cell lymphoma Angioimmunoblastic T-cell lymphoma B-cell prolymphocytic leukemia Burkitt's lymphoma Chronic lymphocytic leukemia Chronic myelogenous leukemia Cutaneous T-cell lymphoma Diffuse large B-cell lymphoma Follicular lymphoma Hairy cell leukemia Hepatosplenic T-cell lymphoma Hodgkin's lymphoma Intravascular large B-cell lymphoma Large granular lymphocytic leukemia Lymphoplasmacytic lymphoma Lymphomatoid granulomatosis Mantle cell lymphoma Marginal zone B-cell lymphoma Mast cell leukemia Mediastinal large B cell lymphoma Multiple myeloma/plasma cell neoplasm Myelodysplastic syndromes Mucosa-associated lymphoid tissue lymphoma Mycosis fungoides Nodal marginal zone B cell lymphoma Non-Hodgkin lymphoma Precursor B lymphoblastic leukemia Primary central nervous system lymphoma Primary cutaneous follicular lymphoma Primary cutaneous immunocytoma Primary effusion lymphoma Plasmablastic lymphoma Sézary syndrome Splenic marginal zone lymphoma T-cell prolymphocytic leukemia
Like dry ice, the main use of liquid nitrogen is for cooling to low temperatures. It is used in the cryopreservation of biological materials such as blood and reproductive cells (sperm and eggs). It is used in cryotherapy to remove cysts and warts on the skin by freezing them. It is used in laboratory cold traps, and in cryopumps to obtain lower pressures in vacuum pumped systems. It is used to cool heat-sensitive electronics such as infrared detectors and X-ray detectors. Other uses include freeze-grinding and machining materials that are soft or rubbery at room temperature, shrink-fitting and assembling engineering components, and more generally to attain very low temperatures where necessary. Because of its low cost, liquid nitrogen is often used for cooling even when such low temperatures are not strictly necessary, such as refrigeration of food, freeze-branding livestock, freezing pipes to halt flow when valves are not present, and consolidating unstable soil by freezing whenever excavation is going on underneath.
Modern definitions are concerned with the fundamental chemical reactions common to all acids. Most acids encountered in everyday life are aqueous solutions, or can be dissolved in water, so the Arrhenius and Brønsted–Lowry definitions are the most relevant. The Brønsted–Lowry definition is the most widely used definition; unless otherwise specified, acid–base reactions are assumed to involve the transfer of a proton (H+) from an acid to a base. Hydronium ions are acids according to all three definitions. Although alcohols and amines can be Brønsted–Lowry acids, they can also function as Lewis bases due to the lone pairs of electrons on their oxygen and nitrogen atoms.
=== Impact of Coronavirus and CARES Act of 2020 === The COVID-19 pandemic in the United States impacted the economy significantly beginning in March 2020, as businesses were shut-down and furloughed or fired personnel. About 16 million persons filed for unemployment insurance in the three weeks ending April 9. It caused the number of unemployed persons to increase significantly, which is expected to reduce tax revenues while increasing automatic stabilizer spending for unemployment insurance and nutritional support. As a result of the adverse economic impact, both state and federal budget deficits will dramatically increase, even before considering any new legislation. To help address lost income for millions of workers and assist businesses, Congress and President Trump enacted the Coronavirus Aid, Relief, and Economic Security Act (CARES) on March 18, 2020. It included loans and grants for businesses, along with direct payments to individuals and additional funding for unemployment insurance. Some or all of the loans may ultimately be paid back including interest, while the spending measures should dampen the negative budgetary impact of the economic disruption. While the law will almost certainly increase budget deficits relative to the January 2020 10-year CBO baseline (completed prior to the Coronavirus), in the absence of the legislation, a complete economic collapse could have occurred. CBO provided a preliminary score for the CARES Act on April 16, 2020, estimating that it would increase federal deficits by about $1.8 trillion over the 2020-2030 period.
2-Mercaptoethanol is the organosulfur compound with the formula HOCH2CH2SH. It is a colorless liquid. ME or βME, as it is commonly abbreviated, is used to reduce disulfide bonds. It is widely used because the hydroxyl group confers solubility in water and lowers the volatility. Due to its diminished vapor pressure its rotten egg odor is less objectionable than related thiols.
Sources: en.wikipedia.org
From this revolution, the 1950s also saw the advent of paper chromatography, reversed-phase partition chromatography (RPC), and hydrophobic interaction chromatography (HIC). The first gels for use in LC were created using cross-linked dextrans (Sephadex) in an attempt to realize Synge's prediction that a unique single-piece stationary phase could provide an ideal chromatographic solution. In the 1960s, polyacrylamide and agarose gels were created in a further attempt to create a single-piece stationary phase, but the purity of and stability of available components did not prove useful for implementation in the HPLC. In this decade, affinity chromatography was invented, an ultra-violet (UV) detector was used for the first time in conjunction with LC, and, most importantly, the modern HPLC was born. Csaba Horvath led the development of modern HPLC by piecing together laboratory equipment to suit his purposes. In 1968, Picker Nuclear Company marketed the first commercially available HPLC as a “Nucleic Acid Analyzer.” The following year, the first international symposia on HPLC was held, and Kirkland at DuPont was able to functionalize controlled porosity pellicular particles for the first time. The 1970s and 1980s witnessed a renewed interest in separations media with reduced interparticular void volumes. Perfusion chromatography showed, for the first time, that chromatography media could support high flow rates without sacrificing resolution. Monoliths aptly fit into this new class of media, as they exhibit no void volume and can withstand flow rates up to 9mL/minute.
Warden III, who largely planned the USAF attacks; within ten minutes of the attacks by 21 F117 aircraft on 38 targets, Iraq had lost its communications and radar; Lt-Col David Deptula; in the first wave were 4 Saudi Arabian Tornado aircraft, 4 Grumman A-6 Intruder and SEAD McDonnell Douglas F-4G Wild Weasel V aircraft, 5 Northrop Grumman EA-6B Prowler aircraft to provide electronic jamming of the Iraq airspace, and 21 McDonnell Douglas F/A-18 Hornet aircraft, each which dropped the AGM-88 HARM anti-radiation missile, to destroy the Iraq surface to air missile capability; Tomahawk missiles were fired from battleships in the Gulf and submarines in the Red Sea; the General Dynamics F-111 had around four thousand gallons of fuel; before advanced guidance systems for munitions, munitions would land according to the circular error probability, which was around a half-mile for a B-17 in World War II; the first laser-guided munitions were the Pave Tack system, which debuted on the F-111 in 1982, first deployed by F-111 aircraft from RAF Lakenheath; Duncan Lennox, editor of Jane's Strategic Weapon Systems; Theodore Postol; on one evening, twenty-eight MIM-104 Patriot missiles were launched against five ballistic missiles, which had broken up on re-entry to the earth's atmosphere - hitting any of these fractured ballistic missiles was almost impossible, due to the unforeseen changing aerodynamics; Lt-Col George Cusimano, deputy director of the USAF joint; the joint also deployed synthetic-aperture radar, to give a fuller view of ground forces, from the AN/APG-76 Doppler radar; the ground picture could be relayed to ground forces, such as in the Battle of Khafji on 29 January 1991; Royal Scots 1st Battalion, with GKN Warrior tracked armoured vehicles and Major John Potter; the experimental Ferranti TIALD laser-guided munitions were deployed by RAF Panavia Tornado aircraft to destroy Iraq hardened aircraft shelters in February 1991; 39th Regiment Royal Artillery deployed the M270 Multiple Launch Rocket System (MLRS); the land battle began on 24 February 1991, watched by the DOAE in Surrey; the land war did not last long, and on 26 February 1991 retreating Iraqi vehicles and tanks were systematically destroyed by AGM-114 Hellfire missiles, launched from undetected Boeing AH-64 Apache helicopters, resulting in total destruction; the USS Wisconsin battleship fired at Failaka Island, with surveillance provided by its AAI RQ-2 Pioneer drone. Narrated by Edward Hardwicke, directed by Chris Haws, produced by Richard Melman, made by InCA Productions 18 August The Healing Mind, about the field of psychoneuroimmunology; psychiatrist Janice Kielcolt-Glaser of Ohio State University College of Medicine; psychologist Barrie R. Cassileth; chemical pathologist Malcolm Carruthers takes a blood sample from a candidate, who has been driven around Brands Hatch at 115 mph; Theodore Melnechuk of the University of California; the body's immune system - the phagocytes destroy foreign bacteria, the natural killer cells destroy the body's own cells that are too damaged, and the lymphocyte T cells and B cells remember pathogens, with a corresponding antibody; experimental psychologist Robert Ader of the University of Rochester Medical Center conducted research on rats in 1975, with cyclophosphamide, which weakens the immune system, and immunologist Nicholas Cohen; prolonged secretion of endogenous opioid peptides may lower the immune function; neuroscientist David L. Felten of the University of Rochester; psychoimmunologist Nick Hall of the University of South Florida College of Medicine and an experiment with drama students, where lowering of T cells was found; Kathleen Dillon of Western New England College, where an experiment measured Ig A of candidates who watched types of television content, and found that Ig A temporarily increased with amusing content; psychiatrist Fawzy Fawzy of the University of California; psychiatrist Margaret Kemeny of UCLA. Narrated by Geoff Watts (of Radio 4's former Science Now series, produced by Geoff Deehan in the 1970s), directed by Yavar Abbas, produced by Geoff Deehan, made by Sandlin Productions 25 August Spacesuit, the spacesuits that astronauts wore during the Apollo missions to the Moon, and whether such spacesuits would be advanced enough to be worn for future missions to Mars; by 2020, NASA expected to have landed on Mars; at sea-level, air pressure is 14 PSI; ILC Dover in Newark, Delaware has made all NASA spacesuits since the late 1960s; medical research at the Ames Research Center; Joe Kosmo, head of NASA spacesuit design; the invention of the defecation-mitten by Matthew Radnofsky; Bruce Webbon of the Ames Research Centre; the Johnson Space Center also worked on suit design. Directed by Patrick Uden, made by Uden Associates 1 September The Falls, about the Niagara Falls. Produced by Clare Odgers, made by the National Film Board of Canada and Primitive Features 8 September Re-inventing Japan, looking at Japan's success in applied science, contrasted with less success in pure science and whether Japan could enhance its pure science industry enough, which has connections with a country's own cultural values and outlook, and how Britain has excelled in pure science, but how much that university funding cuts could erode Britain's prowess in pure science; Japan few Nobel prizes, but excelled at applied science and exploiting others' research by reverse engineering; Canon had £6bn of sales, of which 40% were photocopiers, such as the L5; Hajime Mitarai, research director of Canon, and how Canon had eight product divisions, with their own engineering staff in each division, with process physicists and inorganic chemists; with Western science innovations, it often came from a set of individuals, whereas Japan's innovation culture revolved around much intense group cooperation, not individuals; Japan had only won five Nobel prizes since the 1950s - the US had won 135; a youthful Matt Ridley of The Economist; Fujitsu was the world's second-largest manufacturer of computers, and had bought ICL (which had been Ferranti) in 1990, and sold £10bn a year; Naoki Yokoyama and Takahiko Misugi of Fujitsu; Japan could not rely on other countries research anymore, and had to conduct more in-house research; Japan's culture was not greatly known for originality or taking risks, or being surprised; pathologist Sir Anthony Epstein and how Japan greatly revered tradition, and conformity, possibly viewing anyone who didn't likewise confirm as troublesome; electrical engineer Hiroya Fujisaki, of Tokyo University and known for the Fujisaki model, and that he thought that Japan's culture had historically eroded originality; the national research organisation Riken was formed in 1917, and made great progress, with a large cyclotron, and visited by Einstein in December 1922, but the US was suspicious after the war, and destroyed Riken's cyclotron; Minoru Oda, head of Riken from 1988 to 1993; the US distrusted Japan, and preferred Japan to work on mainly applied science; physicist Akira Tonomura at the Hitachi Advanced Laboratory, which had the world's largest electron microscope; Shojiro Asai of Hitachi; the Canon Advanced Research Laboratory; the Tsukuba Science City and the University of Tsukuba, built by the Japanese government for £6bn, and home of the Japanese ERATO science innovation agency; Genya Chiba, director of ERATO; Michio Nagai, former minister of education in the mid-1970s. Directed by Bob Bee, produced by Michael Wills (later Labour MP from 1997 to 2010 for North Swindon), and made by Juniper Productions 13 September Theme Park Heaven, Walt Disney; Sylvère Lotringer of Columbia University; Arrow Dynamics of California, with Dal Freeman Ron Toomer; David Lewis; Cedar Point, built by Custom Coasters International of Cincinnati; Eric Westin of Walt Disney Imagineering, and the Big Thunder Mountain Railroad ride; Marc Davis, who drew Tinkerbell in Peter Pan, and who worked on the Pirates of the Caribbean ride, which opened in 1967; Larry Lester and David Codiga of Universal Studios, and their earthquake Studio Tour and Backdraft rides; Dreamland in 1912; psychologist Timothy Leary; Douglas Trumbull and the Back to the Future: The Ride and Luxor Las Vegas; Stan Kinsey of SimEx-Iwerks; Michael Ryder and Thom Dickeson of Evans & Sutherland, and texture mapping onto polygons, a main feature of transportation simulations; Bob Stone of the Advanced Robotics Research Centre at the University of Salford. Narrated by Richard O'Brien, produced by Jerome Kuehl, directed by Graham Moore, made with WGBH and Open Media 22 September The Professor's New Clothes, a re-broadcast of an Australian documentary about Professor Vishwa Jit Gupta of Panjab University and his fraudulent work about paleontology of the Himalayas. Directed by Stephen Ramsey, produced by Janet Bell, and made by Film Australia 29 September The Gambler's Guide to Winning, the ways of deploying mathematical techniques to win in gambling, with probability theory methods developed by Prof Edward O. Thorp of University of California, Irvine; the disastrous 1967 Grand National, where nearly all the horses fell at the 23rd fence; Frank Honywill George of Brunel University; Ralph Abraham of University of California, Santa Cruz; Peter A. Griffin of California State University, Sacramento; the gambler's fallacy; J. Doyne Farmer of the Santa Fe Institute. Narrated by Andrew Burt, directed by Julian Nott (son of the Conservative former defence secretary Sir John Nott, who later composed the music for Wallace and Gromit films such as The Wrong Trousers), produced by Jenny Barraclough, made by Peninsula Films 6 October Superpowers?, with Ray Hyman, about the international group of sceptics Committee for Skeptical Inquiry, who dispute topics such as UFOs, made by Open Media 13 October The Lean Burn Machine, about the development of catalytic converters for automotive engines, and how they cause more fuel to be burned than before, and the British engineer Geoffrey West who has produced an alternative, but faced restrictions from EC (EU) legislation; Europe introduced pollution legislation in July 1992; California had the worst vehicle pollution in the US, notably LA; the Clean Air Act; Rob Searles of Johnson Matthey; German environment minister Bernd Schmidbauer - Germany had over two-thirds of European car exports to the US; French physicist Hubert Curien, Minister of Higher Education, Research and Innovation from 1988 to 1993; chemistry graduate Margaret Thatcher being interviewed on 2 March 1989 on the BBC, and lean-burn engines; Bernard Bertrand, head of engine development of Peugeot; Shillington of BL; the new EC legislation in 1992 would outlaw lean-burn powered cars; Dutch automotive writer Gerard Sauer. Narrated by Nick Ross, directed by Nick Abson and Simon Broom, produced by Michael Blakstad (Editor from 1974 of Tomorrow's World), made by Workhouse 20 October The Elements, the poet Roger McGough narrates poetry for each element and how the Periodic Table came to be formed; 5% of the Earth's crust is iron; xenon is found in strobe lights; argon is in domestic incandescent light bulbs; the light bulb filament is tungsten, but reserves of tungsten are low. Directed by Ian Duncan, produced by David Dugan, made by Windfall Films (part of Argonon). Shown on 25 November 1992 on The Nature of Things in Canada 27 October The Strange Case of Crop Circles, an update to the documentary made in 1990, looking at why the 250 crop circles that appeared in the summer, that around 50% of the circles appeared in Wiltshire; the phenomenon took off after a circle near Westbury was pictured in a local newspaper in 1980; Tim Carson charged £1 per visitor to a circle in 1990, and 7,000 visited the Eastfield Pictogram at Alton Barnes, near Milk Hill; Steve Woolgar; Sir Francis Graham-Smith of the Royal Society, who dismissed those people interested in crop circles as mixed company who talked a lot of rubbish and it was a profit-less business to get involved with people who were completely hooked on the unknown; Serena Roney-Dougal; a youthful-looking Matt Ridley of The Economist said that since episodes with nuclear power in the 1970s, people had questioned evidence that scientists had told them; physicist Terence Meaden, who founded TORRO; Yoshi-Hiko Ohtsuki of Waseda University, who researched ball lightning. Narrated by Gavin Weightman, directed by Jill Freeman, and produced by her husband Michael Wills, made by Juniper Productions 3 November Human Waste, new ways of treating excrement such as dry compost toilets, oxidation pools and greenhouses. Directed by Kate Woods (Australian), made by John Blake Associates
==== Infrared spectroscopy ==== The C-H stretching mode gives strong absorptions between 2850 and 2960 cm−1 and weaker bands for the C-C stretching mode absorbs between 800 and 1300 cm−1. The carbon–hydrogen bending modes depend on the nature of the group: methyl groups show bands at 1450 cm−1 and 1375 cm−1, while methylene groups show bands at 1465 cm−1 and 1450 cm−1. Carbon chains with more than four carbon atoms show a weak absorption at around 725 cm−1.
== Usage during original Cold War == The phrase "new Cold War" was first used in 1955 by US secretary of state John Foster Dulles, and in a 1956 New York Times article warning of Soviet propaganda promoting the Cold War's resurgence. Other analysts, such as academics Fred Halliday, Alan M. Wald, David S. Painter, and Noam Chomsky, used the interchangeable terms to refer to the 1979–1985 or 1985–1991 phases of the Cold War. Some other analysts used similar terms to refer to the Cold War of the mid-1970s. Columnist William Safire argued in a 1975 New York Times editorial that the Nixon administration's policy of détente with the Soviet Union had failed and that "Cold War II" was then underway. Academic Gordon H. Chang used the term "Cold War II" to refer to the Cold War period after the 1972 meeting in China between US president Richard Nixon and Chinese Communist Party chairman Mao Zedong.
A human chimera is a human with a subset of cells with a distinct genotype than other cells, that is, having genetic chimerism. An organism that contains a mixture of human and non-human cells would be a human–animal chimera.
Sources: en.wikipedia.org
It is a modified version of the natural hormone, with three amino acid changes and a fatty acid side chain added. These edits extend its half-life from minutes to about one week. The core receptor activity is retained.
Both deliver the same active peptide and act on the same receptor. The tablet includes an absorption enhancer because peptides are poorly taken up intact from the gut. Bioavailability of the oral route is substantially lower, so the two are not dose-equivalent.
No, it is entirely synthetic and does not occur in nature. Native GLP-1 is produced in the gut and pancreas, but the analog is manufactured by chemical synthesis or recombinant methods. Traces of the analog are not expected in people who never received it.
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and neutral endopeptidases. Semaglutide carries a non-natural amino acid at position eight that blocks that cleavage, and a fatty diacid side chain that binds albumin. The result is a much longer duration of action than the native hormone.